SciELO - Scientific Electronic Library Online

 
vol.155 número3Prevalence of pericardial effusion in systemic diseasesAlelos HLA más comunes y asociados con riesgo o protección en enfermedad renal crónica de etiología no determinada índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Gaceta médica de México

versión On-line ISSN 2696-1288versión impresa ISSN 0016-3813

Resumen

KAMMAR-GARCIA, Ashuin et al. Relación de la hiperuricemia con las alteraciones metabólicas y factores de riesgo cardiovascular en jóvenes mexicanos. Gac. Méd. Méx [online]. 2019, vol.155, n.3, 06.  Epub 01-Jul-2021. ISSN 2696-1288.  https://doi.org/10.24875/gmm.19004811.

Introduction:

Hyperuricemia is a risk factor for cardiovascular disease, but its impact has not been properly documented.

Objective:

To assess the impact of hyperuricemia on metabolic parameters and cardiovascular risk factors (CRF) in apparently healthy Mexicans.

Method:

Cross-sectional study of 768 young adults. Association of hyperuricemia with alterations in metabolic parameters and CRF (hypertension, mixed dyslipidemia, metabolic syndrome) was sought. Log-linear and regression models were used to determine the influence of hyperuricemia. A multivariate analysis of variance was applied to observe the interaction of hyperuricemia and overweight or obesity with changes in metabolic parameters.

Results:

Metabolic parameters were higher in patients with hyperuricemia than with normal uric acid (all < 0.05). Hyperuricemia was significantly associated with hypertension (OR=6.8, 95 % CI: 1.1-46), dyslipidemia (OR=2.5, 95% CI: 1.3-4.7) and metabolic syndrome (OR=2.3, 95% CI: 1.1-4.6). Hyperuricemia and overweight or obesity significantly predict changes in cardiovascular risk metabolic parameters (Wilks’ l=0.91, F (6.175)=3.1, p=0.007).

Conclusions:

Hyperuricemia is significantly associated with metabolic alterations and different CRF.

Palabras llave : Uric acid; Cardiovascular risk; Hypertension; Dyslipidemia; Metabolic syndrome.

        · resumen en Español     · texto en Español     · Español ( pdf )